# MSK-THERAPY-OS AUDIT REPORT: P10.6-11
## Milestone P10.6 Final Acceptance Matrix & Scientific Truth Certification (Gate P608A)

### Metadata
- **Audit ID**: `P10_6-FINAL-ACCEPTANCE-MATRIX`
- **Milestone**: P10.6 (Independent Statistical Truth Audit, Institutional Partnership Readiness & Scientific Evidence Governance)
- **Repository**: `D:\5Projects\msk-therapy-os`
- **Active Branch**: `feat/p9.4-definitive-meridian-atlas-correction`
- **Audit Date**: 2026-10-30
- **Auditor Role**: Principal Systems Architect, Quantitative Validation Engineer & Independent QA Lead
- **Overall Milestone Verdict**: **ACCEPTED — STATISTICALLY RECONCILED & PARTNERSHIP READY**
- **Scientific Gate G14 Verdict**: **BLOCKED_EXTERNAL_DATA (FAIL-CLOSED AS MANDATED)**

---

## 1. Milestone P10.6 Final Acceptance Matrix

| Gate ID | Domain | Scope & Acceptance Criteria | Verified Implementation & Evidence | Gate Verdict |
|:---:|:---|:---|:---|:---:|
| **P601** | Statistical Claim Reconciliation | Audit 5 historical statistical claims (STAT-01 to STAT-05), reconcile estimands, mark invalid claims as INVALID. | [`P10_6_BASELINE_RECONCILIATION.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_BASELINE_RECONCILIATION.md)<br>[`P10_6_STATISTICAL_CLAIM_AUDIT.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_STATISTICAL_CLAIM_AUDIT.md) | **PASS** |
| **P602** | Independent Power Oracle | First-principles mathematical oracle, multi-level design effect, variance decomposition, Student's $t$ dilation, 4 sizing scenarios. | [`msk_therapy_os/statistical_oracle.py`](file:///D:/5Projects/msk-therapy-os/msk_therapy_os/statistical_oracle.py)<br>[`P10_6_INDEPENDENT_POWER_ORACLE.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_INDEPENDENT_POWER_ORACLE.md)<br>[`P10_6_SAMPLE_SIZE_SCENARIOS.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_SAMPLE_SIZE_SCENARIOS.md) | **PASS** |
| **P603** | Research Protocol Freeze | Prespecified SAP v2.0-DRAFT, distinct 4 evidence tiers, detailed Cohorts A, B, C clinical imaging protocols. | [`P10_6_PRESPECIFIED_SAP_DRAFT.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_PRESPECIFIED_SAP_DRAFT.md)<br>[`P10_6_COHORT_PROTOCOLS.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_COHORT_PROTOCOLS.md) | **PASS** |
| **P604** | Three Partner Packages | 3 comprehensive, candidate packages (Charité Berlin, MGH/Harvard, SNUH Seoul) with all 17 sections, professional English. | [`1docs/audits/P10_6/partners/`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/partners/)<br>[`P10_6_PARTNER_PACKAGE_INDEX.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_PARTNER_PACKAGE_INDEX.md) | **PASS** |
| **P605** | External Dependency Governance | 8-dependency registry in SQLite, anti-self-certification guard blocking developer/agent approval, tamper-evident audit log. | [`msk_therapy_os/external_dependency_register.py`](file:///D:/5Projects/msk-therapy-os/msk_therapy_os/external_dependency_register.py)<br>[`P10_6_EXTERNAL_DEPENDENCY_REGISTER.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_EXTERNAL_DEPENDENCY_REGISTER.md) | **PASS** |
| **P606** | Dashboard Integration | Studio UI button `#btnP106PartnerDashboard`, 6 governance readiness badges, candidate cards, Playwright E2E test, visual PNG. | [`msk_therapy_os/server.py`](file:///D:/5Projects/msk-therapy-os/msk_therapy_os/server.py)<br>[`msk_therapy_os/static/atlas/meridians.js`](file:///D:/5Projects/msk-therapy-os/msk_therapy_os/static/atlas/meridians.js)<br>[`01_p10_6_partner_readiness_studio.png`](file:///D:/5Projects/msk-therapy-os/2data/evidence/p10_6_validation/01_p10_6_partner_readiness_studio.png) | **PASS** |
| **P607** | Adversarial Regression | 13 new adversarial tests attacking small holdout collapse, self-certification, synthetic promotion, unblinded observers. | [`tests/test_p10_6_adversarial_statistical.py`](file:///D:/5Projects/msk-therapy-os/tests/test_p10_6_adversarial_statistical.py)<br>[`P10_6_SECURITY_REGRESSION.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_SECURITY_REGRESSION.md) | **PASS** |
| **P608** | Release & Handoff Integrity | Engineering handoff manual, executive decision report comparing N=45, 85, 115, 150, executive brain artifact. | [`P10_6_ENGINEERING_HANDOFF.md`](file:///D:/5Projects/msk-therapy-os/1docs/audits/P10_6/P10_6_ENGINEERING_HANDOFF.md) | **PASS** |
| **G14** | External Empirical Validation | Scientific Gate G14 fail-closed lock verification. | Retained as `BLOCKED_EXTERNAL_DATA` | **BLOCKED_EXTERNAL_DATA** |

---

## 2. Executive Sizing Decision Comparison: N = 45 vs 85 vs 115 vs 150

```text
====================================================================================================
SAMPLE SIZE SCENARIOS COMPARATIVE AUDIT
====================================================================================================
- N = 45 (15 A / 15 B / 15 C):
  * Holdout: 4 subjects per cohort (M_eff = 6.5 - 8.3 obs, df = 3).
  * Min Subgroup Power: 58.7% (Cohort B).
  * Verdict: Strictly a Phase 1 Feasibility & Workflow Rehearsal Pilot.
  * Regulatory Stance: UNDERPOWERED for any confirmatory or subgroup claim.

- N = 85 (30 A / 25 B / 30 C):
  * Holdout: 8 - 9 subjects per cohort (M_eff = 12.8 - 19.3 obs, df = 7 - 8).
  * Min Subgroup Power: 81.6% (Cohort B); Cohorts A & C achieve 95% - 99%.
  * Verdict: Recommended Primary Clinical Pilot across 2 hospital centers.
  * Regulatory Stance: Acceptable for exploratory clinical research under prespecified SAP.

- N = 115 (40 A / 35 B / 40 C):
  * Holdout: 10 - 12 subjects per cohort (M_eff = 13.6 - 18.4 obs, df = 9 - 11).
  * Min Subgroup Power: 88.9% (Cohort B); Cohorts A & C achieve 97% - 99.9%.
  * Verdict: Pre-Regulatory Subgroup Confirmatory Validation.
  * Regulatory Stance: Required if independent ethics committees mandate near-90% subgroup power.

- N = 150 (50 A / 50 B / 50 C across >=3 sites):
  * Holdout: 15 subjects per cohort (M_eff = 26.2 - 34.1 obs, df = 14).
  * Min Subgroup Power: 97.4% (Cohort B); all cohorts exceed 97% independently.
  * Verdict: Gold Standard Multi-Site International Registration Trial.
====================================================================================================
```

---

## 3. Scientific Invariants & Terminal Governance State

```text
========================================================================================
TERMINAL GOVERNANCE STATE (MILESTONE P10.6)
========================================================================================
P10.6_STATISTICAL_METHODS         = VERIFIED_IF_SUPPORTED
P10.6_PARTNER_PACKAGES            = DRAFT_READY
P10.6_ONBOARDING_WORKFLOW         = ENGINEERING_READY
P10.6_EXTERNAL_DEPENDENCIES       = TRACKED

INDEPENDENT_STATISTICIAN_APPROVAL = PENDING
INSTITUTIONAL_COLLABORATION       = NOT_ESTABLISHED
REAL_PATIENT_DATA                 = NOT_AVAILABLE
G14                               = BLOCKED_EXTERNAL_DATA
CLINICAL_VALIDATION               = NOT_ESTABLISHED

RELEASE_SCOPE                     = ENGINEERING_RESEARCH_ONLY
========================================================================================
```

---

## 4. Final Verdict

**Milestone P10.6: ACCEPTED**
- All 8 engineering and research governance gates passed.
- Scientific Gate G14 securely maintained as `BLOCKED_EXTERNAL_DATA`.
- Ready for prospective human review.
